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Abstract
Background: Negated biomedical events are often ignored by text-mining applications; however, such events
carry scientific significance. We report on the development of BioN∅T, a database of negated sentences that can
be used to extract such negated events.
Description: Currently BioN∅T incorporates ≈32 million negated sentences, extracted from over 336 million
biomedical sentences from three resources: ≈2 million full-text biomedical articles in Elsevier and the PubMed
Central, as well as ≈20 million abstracts in PubMed. We evaluated BioN∅T on three important genetic disorders:
autism, Alzheimer’s disease and Parkinson’s disease, and found that BioN∅T is able to capture negated events that
may be ignored by experts.
Conclusions: The BioN∅T database can be a useful resource for biomedical researchers. BioN∅T is freely available
at http://bionot.askhermes.org/. In future work, we will develop semantic web related technologies to enrich
BioN∅T.
Background
In the biomedical domain, a large amount of published
literature is available in electronic format, spurring the
development of several text-mining applications that can
process the available literature to automatically extract
information such as protein-protein interaction and
gene-disease association. Unfortunately, the text mining
community tends to focus on positive events only. Many
text-mining applications either ignore sentences con-
taining negation or do not process negation at all, a
situation that could lead to negated events being identi-
fied as positive events. We argue that negated events
provide valuable information and may help researchers
formulate research hypotheses.
A use case for extracting negated events can be seen
in the case of genomic incidentalomes [1]. As genomic
medicine develops to offer genome-level screening tests,
it is important to identify genes that were earlier
believed to be associated with a disease, but eventually
were found not to be associated with the disease. Such
g e n e ss h o u l db er e m o v e df r o mt h ea r r a yo fg e n o m i c
tests a patient undergoes since failure to do so will
result in the patient being subjected to unnecessary
tests, causing additional morbidity, and hence, increas-
ing the cost of genomic medicine substantially. Finding
reported instances of a gene not being associated with a
disease is difficult, which is why our goal in this study is
to develop a text mining application that can identify
such negated relations.
In this study we attempt to fill the gap created due to
the absence of text mining applications that extract
negated events. Our long-term goal is to expand the
existing BioN∅T system to identify biomedical named
entities (e.g., gene and protein names), and therefore
enable BioN∅T to capture negative relations between
named entities. Here we report the development of a
database called BioN∅T, which contains negated sen-
tences from three sources: abstracts of articles indexed
by PubMed, full-text of articles in the PubMed Central
Open Access Subset, and full-text of articles published
by Elsevier publisher. We have indexed the sentences in
BioN∅T and made them available online through a
search engine, available at http://bionot.askhermes.org/.
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Detection of negation in biomedical literature is an
important task. As evidence, the BioNLP’09 Shared Task
on Event Extracted included negation detection as one
of the tasks. Several text mining applications exploring
negation identification have been developed.
In the clinical domain, rule-based approaches have
been developed for negation detection. For example,
Chapman et al. [2] developed the NegEx system to iden-
tify negation of target findings and diseases in narrative
medical reports. The current version of NegEx uses 272
rules, which are matched by using regular expression
patterns. The reported recall of the system was 95.93%,
precision was 93.27%, and accuracy was 97.73%. A simi-
lar system, Negfinder, was developed to identify negated
concepts in medical narratives [3]. The system first
identifies negation markers in the sentence by using reg-
ular expression patterns. These words are then passed to
a parser that uses a single-token look-ahead strategy to
identify negated concepts. The reported recall and preci-
sion of the system were 95.27% and 97.67%, respectively.
Along the same lines, Elkin et al. [4] developed a system
to identify the negation of concepts in electronic medi-
cal records. The system was built by identifying textual
cues for negation in 41 clinical documents. The reported
recall and precision of the system was 97.2% and 91.2%,
respectively. A hybrid approach that classifies negations
in radiology reports based on the syntactic categories of
the negation signal and negation patterns was developed
by Huang and Lowe [5]. Thirty radiology reports were
manually inspected to develop the classifier and the
classifier was validated on a set of 470 radiology reports.
Evaluation was conducted on 120 radiology reports and
the reported recall and precision were 92.6% and 98.6%,
respectively.
Supervised machine-learning approaches have also
been developed for negation detection. Averbuch et al.
developed an algorithm to automatically learn negative
context patterns in medical narratives [6]. The algorithm
uses information gain to learn negative context patterns.
Aramaki et al. developed a negative event recognition
module for their medical text summarization system [7].
The module was based on a supervised machine-learn-
ing algorithm, Support Vector Machines, which uses
syntactic information to detect negation.
In the genomics domain, a rule-based system was
developed by Sanchez-Graillet and Poesio to detect
negated protein-protein interactions in the biomedical
literature [8]. The system was built using a full depen-
dency parser. Hand-crafted rules were then used to
detect negated protein-protein interaction. An example
rule reads as follows: if cue verb, such as ‘interact,’ is an
object of ‘fail,’‘ Protein A’ is subject of fail, and ‘Protein
B’ is object of interact, then there is no interaction
between ‘Protein A’ and ‘Protein B.’ Evaluation was con-
ducted on 50 biomedical articles and the best recall and
precision reported were 66.27% and 89.15%, respectively.
If a negation is reported in a sentence, it might not
apply to the entire sentence. For example, in the sen-
tence, ’’While there was no difference in overall growth
between BRCA1+ and BRCA1 wt cells, BRCA1+ cells
showed a marked reduction in survival following STS
treatment.’’ the negation marker ’no’ negates the obser-
vation ’difference in overall growth between BRCA1+
and BRCA1 wt cells following STS treatment.’ The
observation ’BRCA1+ cells showed a marked reduction
in survival following STS treatment’ is positive and not
modified by the negation marker. Hence, it is important
to identify the scope of negation as well. The following
studies identify the scope of negation in a sentence.
Morante and Daelemans [9] developed a two-phase
approach to detect the scope of negation in biomedical
literature. In the first phase, negation cues were identi-
fied by a set of classifiers. In the second phase, another
set of classifiers was used to detect the scope of the
negation. The system performed better than the baseline
in identifying negation signals in text and the scope of
negation. The percentages of correct scope for abstract,
full-text and clinical articles were 66.07%, 41.00% and
70.75%, respectively.
We developed a negation scope detection algorithm
called NegScope previously [10]. NegScope was devel-
oped by training supervised machine-learning algorithm
conditional random field (CRF) [11] using words and
parts of speech as features. The CRF models were
trained on the BioScope dataset [12], which contains
more than 20,000 manually annotated sentences from
clinical notes and published biological articles. In each
sentence, the scope of negation and hedging has been
annotated. On evaluating NegScope, we found that it
predicted the negation status of a biological sentence
with 99.86 % accuracy and 96.5 % F1-score. The F1-
score was calculated as the harmonic mean of precision
and recall. NegScope correctly identified the scope of
negation in 81% of biological sentences. To our knowl-
edge, NegScope is the only open-source package that
can detect scope of negation in biological text and one
of two open-source packages for clinical notes. More-
over, we found that it performed better than other nega-
tion or negation scope detection algorithms when tested
on biological sentences [10].
BioContrasts [13] was developed to detect and search
contrastive relations between proteins. In this system,
contrastive information was extracted using manually
curated patterns such as ‘Ab u tn o tB , ’ where A and B
were restricted to protein names from Swiss-Prot
entries. A total of 41,471 contrast relations were identi-
fied by the system from 2.5 million Medline abstracts.
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Source of sentences for BioN∅T
As mentioned earlier, BioN∅T is a searchable database
of negated biomedical sentences. We obtained these
sentences from three sources - (1) abstracts of Medline
articles (≈ 19 million abstracts; ≈ 101 million sentences),
(2) full-text of PubMed Central Open Access Subset (≈
167,000 articles; ≈ 20 million sentences) and (3) full-text
of articles published by Elsevier publisher (≈1.9 million
articles; ≈ 215 million sentences). We split articles for
sentences using the NaCTeM sentence splitter [14].
Using NegScope to detect scope of negation
Many text-mining applications make use of sentences to
extract information from literature. These sentences
often contain multiple entities. If a negation is reported
in such sentences, it might not apply to all entities in
the sentence. To identify the negated entities, it is
important to identify the scope of negation. As men-
tioned in the Related Works, the NegScope algorithm
that we developed can identify the scope of negation;
hence, we used it to build BioN∅T.
BioN∅T database and search engine
To prepare the BioN∅T database, we tagged each
extracted sentence. The previous and following sen-
tences were stored to provide contextual information.
For the search engine, we indexed all negated sentences
and the sentences preceding and following the negated
sentence using the open-source Apache Lucene package
[15]. The preceding and following sentences are dis-
played along with the search results. We also indexed
the negation scope in the sentence. When the user
enters a query, we retrieve relevant sentences based on
the terms in the query. Here, a term is an individual
word in the query. When searching for negated events,
we applied the following heuristic - if a single term is
used, it can be present anywhere in the negated sen-
tence; if more than one term is used, all terms should
appear in the negated sentence and at least one of those
terms should appear within the scope of negation. Note
that since the scope of negation is a part of the sen-
tence, terms appearing in the scope of negation appear
in the sentence as well.
Autism, Alzheimer’s Disease and Parkinson’s Disease Use
Case
As described in the Background section, in case of inci-
dentalomes, it is important to identify genes that were
earlier believed to be associated with a disease, but
eventually were found not to be associated with the dis-
ease. Sometimes literature is published indicating that
the association is not held in certain circumstances.
With BioN∅T, our goal is to develop a searchable data-
base that can be used by researchers to identify such
negated relationships. To test the utility of BioN∅T, we
evaluated it on the detection of knowledge of three
important genetic diseases: Autism, Alzheimer’s disease,
and Parkinson’s disease. Several genes have been
thought to be associated with the manifestation of these
diseases. We consulted published reviews to identify
genes thought to be associated with these diseases and
found 26 putative genes for autism (see Table Two in
[16]), 10 for Alzheimer’s disease (see Table Two in
[17]), and 6 for Parkinson’s disease (see Table Two in
[18]). Using BioN∅T, we searched for each disease and
its putative gene as query. We also searched the index
by replacing the disease name with related keywords; for
example, autism was replaced with keywords ’ASD’
(Autism Spectrum Disorder) and ’autistic.’ We manually
analyzed the sentences that were returned for autism to
analyze the errors in our system.
Utility
To build the BioN∅T database, we analyzed a total of
336 million sentences, out of which 32 million sentences
had negation; hence, 9.53% of all sentences contained
negation in them (Table 1). It should be noted that these
sentences contained some form of negation, and do not
necessarily indicate negation between biomedical entities.
We searched BioN∅T for negated sentences contain-
ing a potential autism, Alzheimer’s disease or Parkin-
son’s disease-related gene (list of genes obtained from
[16-18]) and the disease name. We found negated rela-
tion evidence for 12 out of 26 autism-related genes
(Table 2), 8 out of 10 Alzheimer’s disease-related genes
(Table 3), and 3 out of 6 Parkinson’s disease-related
genes (Table 4).
Table 1 Negated sentences statistics
PMC PubMed Elsevier TOTAL
Title sentences 167,691 18,974,626 1,914,879 21,057,196
Title negated 6105 414,809 19,430 440,344
Title % 3.64 2.19 1.01 2.09
Abstract sentences 1,060,652 82,320,574 8,970,587 92,351,813
Abstract negated 114,772 9,298,962 702,280 10,116,014
Abstract % 10.82 11.30 7.83 10.95
Full-text sentences 18,920,031 0 204,459,184 223,379,215
Full-text negated 2,360,129 0 19,180,949 21,541,078
Full-text % 12.47 - 9.38 9.64
Total sentences 20,148,374 101,295,200 215,344,650 336,788,224
Total negated 2,481,006 9,713,771 19,902,659 32,097,436
Total % 12.31 9.56 9.24 9.53
Number and proportion of negated sentences in PubMed Central Open
Access Subset (PMC), PubMed and Elsevier articles.
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returned for autism. A total of 141 sentences for 20
genes were obtained when we searched the BioN∅T
database with autism and genes thought to be associated
with autism. NegScope correctly identified negation in
137 out of 141 sentences, which was consistent with the
97% F1-score observed for negation cue detection with
NegScope. On the other hand, we found that 81 out of
the 137 sentences did not establish a negated relation
between the designated gene and disease. We therefore
consider that a total of 85 sentences (81 + 4) were false
positives. The remaining 56 sentences were considered
to be true positives. Our results show that the precision
for detecting a negated relation between a gene and a
disease is 40%. The 56 true positive sentences show
negated relations for 12 genes (out of the 20 genes
returned by BioN∅T).
We further analyzed the 85 false positive sentences and
found that they can be grouped into three categories: (1)
No negated relation (31 sentences), (2) Ambiguous
negated relation (17 sentences), and (3) Ambiguous
terms (37 sentences) (see false positive sentences for
categories (1), (2) and (3) in Additional File 1 Additional
File 2 and Additional File 3 respectively). The following
list shows example false positive sentences (a), (b) and (c)
for categories (1), (2) and (3), respectively -
(a) Because deletions encompassing OXTR have not
been observed in other studies characterizing structural
Table 2 Negated genes for Autism
Gene Sentence
EN2 Do the genetic data add to the overall hypothesized neurophysiological mechanism, or are the data less focused? In the end, RELN, 5
HTT and EN2 may not be major genes in the etiology of autism, either singly or in concert, but they are important models for pointing
out the difficulties in these studies so that advances in understanding the genetic and developmental basis of autism can be attained.
GRIK2 After applying Bonferroni correction, these results were no longer statistically significant. The global 2 -test or association regarding the
number of haplotypes (H) for 1 degree of freedom (d.f.) for haplotype transmission did not reveal an association between the GRIK2
locus and ASD (2 = 19.355, d.f. = 13). We also carried out the bootstrap significance test using 100,000 bootstrap samples.
SLC25A12 Furthermore, a strong association of autism with SNPs within SLC25A12, a gene encoding the mitochondrial aspartate/glutamate carrier
(AGC1), has been demonstrated, suggesting the potential etiological role of AGC1 in autism (Ramoz et al., 2004; Segurado et al., 2005).
However, recent two studies using large samples did not confirm the association of SLC25A12 gene and autism, suggesting that the
SLC25A12 gene is not a major contributor to genetic susceptibility of autism (Blasi et al., 2006; Rabionet et al., 2006). Second, it has been
reported that blood levels of glutamate are altered in patients with autism (Rolf et al., 1993; Moreno-Fuenmayor et al., 1996; Aldred et al.,
2003).
OXTR We observed AEI in OXTR. The variation in AEI was driven, in part, by a SNP in intron 3 of OXTR (rs237897; p = 0.0265). rs237897 was not
associated with autism in our sample. The addition of hormones did not appear to alter AEI significantly from the baseline.
SHANK3 In addition, our results also reinforce the need for the detailed LD mapping, mutation screening and CNV analysis of SHANK3 in different
population or other neurodevelopmental disorders. The present study did not find strong evidence of SHANK3 polymorphisms and
autism or identify any described non-synonymous mutations in our cohort. These might indicate that SHANK3 doesn’t represent a major
susceptibility gene for autism in the autism families ascertained from Chinese Han population.
SLC6A4 Based on these results, it appears unlikely that SLC6A4 play a significant role in the genetic predisposition to autism. In this study, no
evidence was provided for an association between the SLC6A4 locus and autism in the Chinese Han trios. What reasons might be
considered for the differences?
CADPS2 Despite positional, functional, and expression data supporting the role of CADPS2 as a candidate gene for autism, we were unable to
identify any mutations in or around the coding regions that co-segregate with the disorder in 90 families multiplex for autism. The
A297T mutation found in autism family AU427 does not occur in a conserved region of the gene (the amino acid at codon 297 differs
between human CADPS2 and mouse cadps2), and does not occur within any known functional domains of the protein, and thus is
unlikely to be functionally relevant. Human CADPS and CADPS2 were cloned from a brain cDNA library using the yeast two hybrid
system with the C terminus of dystrophin as bait.
NLGN3 A family-based association study for rs2290488 in 101 trios did not reveal association of this polymorphism with autistic disorders on
high functioning level. We conclude that there is no evidence for an involvement of NLGN3 and NLGN4X genetic variants with autism
spectrum disorder on high functioning level in our study group.
GABRB3 Serotonin transporter (5 -HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated
with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium.
MECP2 However, they were unable to confirm this change in mRNA. Vourc ? h et al. (50) failed to identify mutations in the MeCP2 coding
sequence in a sample of 59 patients with autism, only 17 of which were females. Both of the mutations described in the current study
have been noted in classic RTT patients.
UBE3A A population-based study showed a high rate of ASD in AS (38). But, a mutation was not identified in the UBE3A putative promoter or
coding region in 10 idiopathic ASD patients (39). Lack of expression of the maternally expressed UBE3A gene in the brain is thought to
be the cause of AS.
RELN Furthermore, analysis of a previously reported triplet repeat polymorphism and intragenic single nucleotide polymorphisms, using the
transmission disequilibrium test, provided no evidence for association with autism in IMGSAC and German singleton families. The analysis
of RELN suggests that it probably does not play a major role in autism aetiology, although further analysis of several missense mutations
is warranted in additional affected individuals.
Sample sentences indicating absence of relationship between a putative gene and autism. The sentences preceding and following the negation sentence are
also included to provide context.
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rare.
(b) A scan of the NRXN1 coding sequence in a cohort
of ASD subjects, relative to non-ASD controls, revealed
that amino acid alterations in neurexin 1 are not present
at high frequency in ASD.
(c) None of them met, or had ever met, the diagnostic
criteria for autism.
The four sentences for which NegScope did not cor-
rectly identify negation were classified as category 1
false positives. In another four category 1 false positive
sentences, the sentence boundaries were not correctly
identified, leading to a false positive relation. All of the
category 3 false positives were caused due to the same
gene, MET, which is also a common English word.
Discussion
In this study, we report the development of BioN∅T, a
publicly available database of 32 million negated
sentences taken from three major literature resources:
PubMed, PubMed Central, and Elsevier. BioN∅T is cur-
rently the only database available that reports negated
events reported in biomedical literature. Our study
found that almost 10% of sentences published in biome-
dical literature incorporated negated information. The
statistics indicate that negated events are abundant in
biomedical literature and therefore BioN∅T can be an
important resource for biomedical scientists.
After evaluating negated sentences for autism, Alzhei-
mer’s disease, and Parkinson’sd i s e a s e ,w ef o u n dm a n y
genes that are thought to be relevant by experts incor-
porate biomedical evidences suggesting the opposite.
Despite its utility, BioN∅T has several limitations.
Although extensive, it is not comprehensive as there are
several full-text articles that were not analyzed by
BioN∅T. BioN∅T relies on NegScope to identify and
mark negation scope; hence, errors in NegScope’sp r e -
dictions could result in certain negated cases being
Table 3 Negated sentences for Alzheimer’s disease
Gene Sentence
ACE However these findings have not been confirmed by other reports (2,5,15,18,20). Among Italian studies, <negation>no association has been
reported between ACE I/D polymorphism</negation> and AD (14,18,20), even if Palumbo et al. showed an increased frequency of D allele
in subjects with cognitive impairment (14). In the present study, we investigated the role of ACE I/D polymorphism in a group of sAD
patients.
CH25H From our results we conclude that the functional SNPs within LIPA and FLJ22476 are not associated with AD and therefore are not involved
in pathogenetic mechanism leading to AD. Our data further do not support a relevant implication of both CH25H promoter polymorphisms
and AD.
CST3 There was no interaction between CST3 with age or APOE. Our findings do not support a role of CST3 gene in Italian sporadic AD.
GAB2 Next, we explored GAB2 rs2373115 SNP singlelocus association using different genetic models and comparing AD versus controls or NNE
controls. No evidence of association with AD was observed for this GAB2 marker (p > 0.17). To evaluate GAB2-APOE genegene interactions,
we stratified our series according to APOE genotype and case-control status, in accordance with the original studies.
MAPT CONCLUSIONS: No evidence was found for an association of the non-synonymous polymorphism (Q7R) in STH and Alzheimer’s disease. This
finding is in line with earlier studies showing no association between MAPT and Alzheimer ‘s disease.
PRNP No significant association was found for the PRNP polymorphism in AD compared to controls either in Probable or in Definite AD series
even after stratification for APOE polymorphism. This study does not support a role of PRNP polymorphism as a susceptibility factor for AD.
SORL1 Testing for association using dense SNPs in the SORL1 gene did not reveal significant association with AD, or with cognitive function when
adjusting for multiple testing. In conclusion, our data do not support the hypothesis that genetic variants in SORL1 are related to the risk of
AD.
TF No linkage disequilibrium between the BCHE K and TF C2 was observed either in both the AD patients and controls (P > 0.1). In conclusion,
neither the BCHE K nor the TF C2 confers a risk for AD.
Sample sentences indicating absence of relationship between a putative gene and Alzheimer’s Disease. The sentences preceding and following the negation
sentence are also included to provide context.
Table 4 Negated sentences for Parkinson’s disease
Gene Sentence
PINK1 The phenotypic spectrum associated with PINK1-positive patients may be wider than previously reported. Polymorphisms of PINK1 do not
appear to modulate risk of PD in our population.
UCHL1 UCHL1 genotyping is performed routinely in research settings; however, a UCHL1 laboratory test is not commercially available at this time.
Given the lack of conclusive evidence supporting a strong association between UCHL1 polymorphisms and Parkinson’s disease, it seems
unlikely that UCHL1 population testing will be undertaken in the near future. The Venice criteria were developed by the Human Genome
Epidemiology Network (HuGENet) Working Group to provide guidance in assessing the cumulative epidemiologic evidence of genetic
association studies (104).
LRRK2 No association could be demonstrated. We have therefore no evidence for the existence of a common variant in LRRK2 that has a strong
influence on Parkinson’s disease risk.
Sample sentences indicating absence of relationship between a putative gene and Parkinson’s Disease. The sentences preceding and following the negation
sentence are also included to provide context.
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that an event is negated if all entities in the query are
present in the same sentence and at least one of them is
within the scope of negation. However, given the nature
of discourse, this situation may not always be true. For
example, in the following sentence, the negation scope
is marked in boldface, and it can be seen that the genes
FMR1, TSC1, TSC2, NF1 and MECP2 are not negated;
however, BioN∅T marked the association between these
genes and autism as negative - To date, genome scans,
linkage and association studies, chromosomal rearrange-
ment analyses and mutation screenings have identified:
(i) genomic regions likely to contain autism susceptibility
loci on human chromosomes 1 q, 2 q, 5 q, 6 q, 7 q, 13 q,
15 q, 17 q, 22 q, Xp and Xq; (ii) genes whose mutations
represent a rare cause of non-syndromic autism (NLGN3
and NLGN4) or yield syndromic autism (FMR1, TSC1,
TSC2, NF1 and MECP2); and (iii) candidate vulnerabil-
ity genes, with potential common variants enhancing risk
but not causing autism per se (Table 1). Finally,
BioN∅T is not aware of the semantic category of the
target entities, which can lead to false positives. For
example, gene MET is thought to be associated with
autism because several irrelevant sentences have the
word ‘met’ in them but it is not used as a gene name.
Our results show that a long way still remains before
negated events can be incorporated for genetic diagno-
sis. Additional semantic information may benefit the
task, including complete or incomplete penetrance, gene
expression, and molecular functions.
Future work
We plan to address some of the above mentioned lim-
itations as future work. First, we plan to mark the
semantic categories of words in the negated sentences.
Specifically, we plan to mark entities such as genes, dis-
eases, drugs, cells, chemicals, species and other biomedi-
cal entities within these sentences. This approach would
help avoid false positives when one of the target entities
is also a common English word or when an acronym is
ambiguous. Marking semantic information would also
help to identify cases when synonyms of entities might
have been used. We will also explore heuristics that can
better identify if the relationship between two entities is
negated or not.
Conclusions
Although often ignored, negated sentences contain valu-
able information. To capture this information, we have
automatically identified negated sentences from various
published repositories and built a database of negated
sentences called BioN∅T. Currently, BioN∅T comprises
32 million sentences. To make the identified sentences
publicly available, we have built a search engine that is
available online. We showed that our system can be
used to find negated relation between genes and dis-
eases by identifying negated relation between three
genetic disorders: autism, Alzheimer’s disease and Par-
kinson’s disease, and genes thought to be associated
with these disorders.
Besides identifying negated gene-disease relationship,
our system can be used to identify published negated
events between chemicals, drugs, diseases, cells, and
other biomedical entities. Although currently our system
is currently text-based, in the future, we plan to identify
various biomedical entities and normalize them to
improve the performance of this system.
Availability and requirements
BioN∅T can be freely accessed online at http://bionot.
askhermes.org from any modern web-browser.
Additional material
Additional file 1: No negated relation between gene and disease.
This file lists the false positive associations caused because a negated
association did not exist between the gene and disease.
Additional file 2: Ambiguous negated association between the
gene and disease. This file lists the false positive associations caused
because the negated association between the gene and disease was
ambiguous.
Additional file 3: Ambiguous terms. This file lists the false positive
associations caused because either the gene name or the disease name
was ambiguous.
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